.

Nicholas D. Bowers

Portrait of Nicholas D. Bowers

As a seasoned litigator, Nick has represented companies, schools and professionals across a range of disciplines in relation to civil and commercial disputes. His representative experience includes construction injury, auto and trucking accident cases as well as products and premises liability matters. Nick represents construction firms, industrial clients and others in relation to catastrophic injury claims, both pre-suit and during litigation, as well as pursuant to OSHA investigations and similar governmental inquiries. Additionally, he represents property management companies in personal injury claims by tenants due to mold exposure.

Nick’s practice also encompasses litigation stemming from construction defect and other property loss. In this regard, he regularly handles cases involving claims for alleged defect(s) and damage arising from negligence as well as the Pennsylvania Unfair Trade Practices Act and Consumer Protection Law. Nick’s experience extends to shipping loss matters, including actions involving the Carmack Amendment.  

Nick’s practice has grown to include the defense of school districts, municipalities and private schools in relation to allegations of abuse. He is cognizant of the complex and sensitive nature of these cases and well-versed in the applicable statutory framework.  

During the course of his career, he has tried cases in a broad range of claims in both Federal and State Courts, obtaining favorable outcomes for clients at trial, arbitration and by way of summary judgment. Since 2017, Nick has been selected by Super Lawyers as a Rising Star in the field of Civil Litigation Defense, a recognition awarded to no more than 2.5 percent of attorneys under the age of 40 in the region.  

Nick also has experience in the area of insurance fraud (“SIU”) litigation. In this role, he handles a wide variety of auto litigation (including BI, UM/UIM and PIP) as well as premises liability matters flagged for suspected fraudulent activity.  

Nick graduated from Loyola University Maryland in 2005. While at Loyola, he was a four-year starter on the NCAA Division One Men’s Tennis Team, serving as captain during his senior year. After Loyola, he was employed on Capitol Hill in Washington, DC at the United States House of Representatives.  In this role, he served as staff for the Committee on Ways and Means, which is the House Committee responsible for formulating bills related to taxation and international trade.

Outside of his practice, Nick enjoys spending time with his family, experiencing the outdoors and riding the highs and lows of Philadelphia sports.

    • Temple University Beasley School of Law (J.D., 2009)
    • Loyola University Maryland (B.A., 2005)
    • New Jersey, 2009
    • U.S. District Court District of New Jersey, 2009
    • Pennsylvania, 2013
    • U.S. District Court Eastern District of Pennsylvania, 2014
    • Pennsylvania Super Lawyers Rising Star (2017-2022)
    • Pennsylvania Bar Association
    • Philadelphia Bar Association
    • Loyola University, Philadelphia Alumni Chapter, Board of Directors
    • Pennsylvania First Party Medical Benefits (PIP): An Overview And Strategies For Effective Claims Handling, Marshall Dennehey Virtual Client Presentation, March 5, 2021
    • An Overview of Pennsylvania Law for Auto & Premises Claims, Marshall Dennehey Virtual Client Presentation, February, 2021
    • Accident Prevention and Investigation: Strategies for Risk Mitigation, Client Presentation, April 2017
    • Pennsylvania First-Party Benefits: An Overview.  Client seminar.  Presented August, 2015.
    • SIU and the Third-Party Liability Case: An Overview and Tactics.  CLE Course.  Presented July, 2015.
    • "Bankruptcy Fraud—Tactics for the Effective Use of a Plaintiff’s Bankruptcy Filing in Defending Civil Claims," Defense Digest, Vol. 19, No. 4, December 2013
    • "Acupuncture Billing Has PIP Carriers on Pins and Needles," SIU Perspectives, Vol. 1, No. 1, October 2013
    • "Winning Legal Strategies for Combating A Prickly Problem 'Sticking' New Jersey Carriers," Defense Digest, Vol. 19, No. 2, June 2013
    • Case Law Alerts, regular contributor, 2012-present
    • Obtained dismissal of clients by Summary Judgment in a Philadelphia premises liability case in which we represented both the landowner and tenant. The plaintiff originally demanded $2 million, later reduced to $800,000. Although our clients were responsible for sidewalk maintenance, the plaintiff’s deposition testimony confirmed she tripped on a smaller portion of an alleged defect which was larger in other areas of the sidewalk. We successfully argued that this portion was de minimis and not actionable under Pennsylvania law. Despite a comprehensive opposition and a Motion for Reconsideration, the Court agreed with our arguments, dismissing all claims against our clients with prejudice.
    • Secured dismissal with prejudice of clients (bar owners) in high value dram shop case involving the unfortunate death of an automobile occupant. Court granted defense motion and found that Plaintiff’s claims were barred as a matter of law.
    • First chair trial counsel in two-week trial at Philadelphia Court of Common Pleas in case involving a catastrophically injured Plaintiff and settlement demand of $25 million. The case and trial involved complex issues pertaining to post-Tincher product liability in Pennsylvania as well as successor liability and statutory employer considerations. Resolved on terms favorable to client prior to verdict.
    • Secured dismissal with prejudice in significant property loss/theft case.  Plaintiff alleged that his landlord stole several artifacts and other materials from him while Plaintiff was out of the country.  Plaintiff testified that he filed for bankruptcy and obtained a discharge after the alleged theft.  Plaintiff did not list his claim against my client on his bankruptcy petition and thus Plaintiff forfeited his post-discharge right to this “asset” (claim) per the United State Bankruptcy Code.  Plaintiff voluntarily dismissed case with prejudice when confronted with bankruptcy evidence and legal argument.
    • Secured summary judgment in favor of large oil refinery based on argument that refinery was the owner out of possession and thus had no control over the premises and therefore had no duty of care with respect to the Plaintiff.
    • Obtained defense verdict in Philadelphia premises liability matter.  Plaintiff alleged she slipped and fell on “dirty water” which accumulated in the lobby of Defendant’s premises.  Defense verdict secured based on Plaintiff’s failure to establish that Defendant had actual or constructive notice of alleged dangerous condition.

Results

Thought Leadership

Defense Digest

Change Is in the Air: A Shift in Pennsylvania Judge’s Role in Jury Selection Effective April 1, 2025

March 1, 2025

Key Points: Effective April 1, 2025, the Supreme Court of Pennsylvania has amended Pa.R.C.P. 220.3, pertaining to voir dire of jurors.  Amended Rule 220.3(a) now provides: “Judge’s Presence Required. Voir dire of prospective jurors shall be conducted, and the jurors shall be selected, in the presence of a judge, unless the judge’s presence is waived by all parties with the consent of the court.” The right to a trial by jury is a hallmark of the justice system in the United States. Juries consist of eight or twelve individuals from a given geographic area, generally lacking legal training, who are asked to decide facts and render verdicts, often of great consequence to the litigants. While jurors must follow the directions of the court, each juror has broad discretion in deciding, among other things, whether or not to believe a witness, how heavily to weigh competing evidence, and in determining whether they are or are not persuaded by arguments of counsel. In light of this, it is perhaps rightly said that many cases are won or lost during jury selection.  In Pennsylvania, attorney control of jury composition is generally limited to voir dire and peremptory challenges. Traditionally, voir dire procedures in Pennsylvania have varied from county to county—with some counties involving judges in the process more than others. In particular, Allegheny and Philadelphia Counties, for example, generally utilized court officers who controlled the voir dire process in the absence of the judge or court reporter.  Recently, however, a significant change in these procedures was adopted, with an effective date of April 1, 2025. Specifically, the Supreme Court of Pennsylvania amended Pa.R.C.P. 220.3, pertaining to voir dire of jurors, to include amended Rule 220.3(a), which now provides the following: “Judge’s Presence Required. Voir dire of prospective jurors shall be conducted, and the jurors shall be selected, in the presence of a judge, unless the judge’s presence is waived by all parties with the consent of the court.” (Emphasis added.) The adoption of amended Pa.R.C.P. 220.3 was preceded by the case of Trigg v. Children’s Hospital of Pittsburgh of UPMC, 187 A.3d 1013 (Pa. Super 2018), which involved an Allegheny County trial where jury selection occurred in the presence of a court clerk as opposed to the trial judge. The plaintiff appealed the jury verdict on, among others, the basis that three jurors should have been stricken for cause due to bias, as evidenced in voir dire, which occurred outside of the presence of the trial judge. The appellant argued the court’s decision not to strike was reversible error, while the appellees took the position that the trial court was entitled to the palpable error deference standard announced in McHugh v. Proctor & Gamble, 776 A.2d 266 (Pa. Super. 2001). Thus, no error warranting overturning the verdict occurred. The Trigg court took note of the fact that jury selection took place outside of the presence of the judge thus, depriving the trial court of the opportunity to assess the credibility of the proposed jurors to any extent beyond reading a transcript. Accordingly, per Trigg, the trial judge had no greater insight into the credibility of the proposed jurors—having not viewed the questioning live and, thus, lacked insight into the reactions of the proposed jurors to the questioning, including hesitation, eye movement or other physical manifestations impacting credibility—than the appellate court. Therefore, McHugh deference was not warranted.  The Superior Court overturned the verdict accordingly.  The Pennsylvania Supreme Court took up the case on appeal from the Superior Court in Trigg v. Children’s Hospital of Pittsburgh of UPMC, 229 A.3d 269 (Pa. 2020). While the Pennsylvania Supreme Court found that the issue in question had been waived due to counsel’s failure to object to the jury selection proceeding in the absence of the judge, the Supreme Court still found the procedure problematic, leading to adoption of amended Pa.R.C.P. 220.3. Amended Rule 220.3 will likely lead to greater uniformity in the jury selection process across counties in Pennsylvania. Unless waived by the parties, voir dire must now occur in the presence of a judge. It is important for practitioners to understand that each party is entitled to have the judge present for voir dire, and this right should not be waived absent an affirmative decision to do so approved by a client.  The Amended Rule may also assist litigants in the preservation of appellate issues, including those relative to a trial court’s decision to strike or decline to strike a juror for cause. The judge will be present along with a court reporter.  *Nick is a member of our Casualty Department. He works in our Philadelphia, Pennsylvania, office.    Defense Digest, Vol. 31, No. 1, March 2025, is prepared by Marshall Dennehey to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. ATTORNEY ADVERTISING pursuant to New York RPC 7.1. © 2025 Marshall Dennehey. All Rights Reserved. This article may not be reprinted without the express written permission of our firm. For reprints, contact tamontemuro@mdwcg.com.

Firm Highlights

Result

No-Cause Jury Verdict Secured in Wrongful Death Trial

We successfully obtained a no-cause jury verdict in a 13-day wrongful death trial. The decedent, a 59-year-old man, was admitted to the emergency room on February 15, 2019, with complaints of abdominal pain, decreased appetite, and constipation, despite the use of laxatives. The patient did not complain of any nausea, vomiting, or diarrhea. He had a significant medical history including diabetes, hypertension, prior coronary artery stenting, morbid obesity (with past gastric bypass surgery), longstanding ventral hernia, and back pain. A CT scan revealed multiple hernias and a potential closed-loop bowel obstruction, leading to a surgery consultation. Our client, an emergency general surgeon, interpreted that the patient did not have a closed loop or any significant obstruction and recommended non-surgical management. The patient was approved to have clear liquids, and had a vomiting incident shortly after, but our client was not notified. The patient was returned to NPO status, and after improving overnight, he was returned to “clears” and additional medical and renal consults were ordered. Our client did not receive any communications from the residents/nurses of any changes in the patient’s condition. On February 18, 2019, two rapid responses were called due to increased heart rate and vomiting. It is believed that the vomiting resulted in aspiration, causing sepsis, ultimately leading to the patient’s death. During the trial, the plaintiff’s sole medical expert highlighted imaging on the wrong hernia, which called into question all of his opinions in the case. We made key objections related to the expert testimony, limiting what the allegations were, and preventing new allegations from being made. After approximately two and a half hours of deliberating, the jury returned a no-cause verdict. 

Thought Leadership

Casual Care, Serious Consequences: How Informal Prescribing Can Trigger Medical Board Scrutiny

The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Consider the following scenario: in December 2025, a medical provider renewed a prescription for a long-standing telemedicine patient receiving a Schedule II controlled dangerous substance. This was not a violation of the New Jersey Administrative Code. Another provider doing the same action for an equally situated patient in March 2026 would be in violation. The casual prescriber who is not aware of newer regulatory requirements may have a more difficult time responding to a medical board complaint. Medicine is a highly-regulated helping profession. Without addressing the merits of this regulatory burden, the practice of medicine continues to see drastic changes impacting the everyday life of patient and provider. Telemedicine, COVID-19, and other advances and roadblocks, present a challenge to those saving lives while attempting to comply with the rules of practice. Physicians often discover—through real cases and the lens of regulatory expectations—that even well-intentioned informal help can be reinterpreted as stepping outside mandated professional boundaries, and seemingly harmless actions can be construed as deviations from required practice standards specifically outlined in Title 13, Chapter 35, Subchapters 7.1A of the New Jersey Administrative Code. Title 45, "Professions and Occupations," of the New Jersey code governs the practice of medicine, nursing, optometry, pharmacy, and many other professional occupations. Section 9 specifically addresses the state board of medical examiners and allows for the creation of rules and regulations in Section 45:9-5.3. These regulations can be found in the New Jersey Administrative Code Title 13, Chapter 35. While broad in scope, Chapter 35 contains a subchapter dedicated to the administration and dispensing of prescription drugs. Such knowledge will arm physicians with the tools they need to prevent a negative outcome if a medical board complaint is filed. Likewise, attorneys must be familiar with these regulatory requirements when advising and defending providers. In New Jersey, N.J.A.C. Section 13:35-7.1A(a) requires that a practitioner conduct an examination and appropriately document the same within the medical record before dispensing drugs or issuing prescriptions. The examination must include an "appropriate history and physical examination," a diagnosis based upon the examination and any testing consistent with good medical care, the formulation of a therapeutic plan discussed with the patient, and the availability of appropriate follow-up care. There are only six exceptions to this requirement: In admission orders for a newly hospitalized patient For a patient of another physician for whom the practitioner is taking calls For continuation medications on a short-term basis for a new patient prior to the patient's first appointment For an established patient who, based on sound medical practice, the physician believes does not require a new examination before issuing a new prescription For a patient examined by a healthcare professional who is in collaborative practice with the practitioner When treatment is provided by a practitioner for an emergency medical condition Emergencies are also limited to situations where someone's health is in serious jeopardy, there is serious impairment to bodily functions, or serious dysfunction of any bodily organ or part. During the COVID-19 pandemic, then New Jersey Governor Phil Murphy issued an executive order declaring a public health emergency and a state of emergency that allowed authorized prescribers to prescribe Schedule II controlled dangerous substances via telemedicine. The order was terminated when he left office earlier this year and the state reverted to the requirement of an initial in-person examination and quarterly in-person visits. With this return to prior regulatory requirements, practitioners subject to the jurisdiction of the board of medical examiners may benefit from a refresher on the regulatory limitations on their practice now that the pandemic-era flexibilities have ended. This new requirement may create confusion for prescribers and lead to casual prescribing of medication in violation of the regulations, even in the setting of recurrent telemedicine appointments as noted in the example above. Casual prescribing can take many forms: filling a prescription request from a friend or family member without an examination or contemporary medical record; using telemedicine to expand your practice without proper in-person appointments or documentation in the medical record; failing to ensure appropriate follow-up care for a "one time" prescription; etc. Although not all board complaints end in a publicly available opinion, serious deviations from regulatory requirements can shine a light on practices that will require action by the board if a complaint is received. Consider the following cases: In October 2025, the board issued a final consent order in an administrative action where a doctor provided opioids without examination and his license was permanently revoked. In re Robert Dela Gente, D.O., N.J. State Bd. of Med. Exam'rs Oct. 21, 2025. Criminal charges were filed (though that is not always the case). In a September 2025 consent order, a physician was reprimanded for "prescribing opioids several months in advance without the proper patient follow-up..." and explained that they did so for "patients who can not pay for multiple visits to refill medications." In re A/an E. Schultz, M.D., N.J. State Bd. of Med. Exam'rs Sept. 25, 2025. Another physician was suspended and placed on probation in a consent order for prescribing three patients the weight-loss medication "Ozempic" via text messages through a website called "Push Health" and without any further communication with the patients or taking a medical history. In re Laura E. Purdy, M.D., N.J. State Bd. of Med. Exam'rs Aug. 29, 2025. A June 2025 interim consent order required a "full evaluation and assessment of [a physician's] general knowledge and skill, with specific emphasis on his knowledge of and ability to safely prescribe [controlled dangerous substances]" due to his failure to review a patient's prior medical history and medical record, assess and review the prescription monitoring program before prescribing CDS, and conduct random urine screens on a patient that tested positive for CDS upon admission to his practice because "he trusted the patient." In re Donald Oh, M.D., N.J. State Bd. of Med. Exam'rs June 2, 2025. Each of these examples demonstrate a failure to follow strict procedure regardless of the intention. Failing to follow procedure secondary to good intentions, such as considering a patient's financial constraints, trust in the patient, or utilizing a new telemedicine service platform, will not be a defense to a board complaint. Especially when practicing via telemedicine, practitioners must ensure they are adhering to the appropriate regulatory standard. A provider who calls in a prescription for a traveling friend or family member or agrees to prescribe medication for individuals using the newest phone app will have a hard time meeting the requirements of N.J.A.C. Section 13:35-7.1A. Even if a history was taken, a "therapeutic plan" was created, and "follow up care" was provided, the prescriber would still not be in compliance with the regulation without an in-person examination. In our opening hypothetical, the prescriber's behavior did not change between December and March; however, the legal shift in the regulatory landscape made once acceptable behavior a violation as a required examination did not occur. When complaints are made with regard to informal prescribing, the board has discretion to employ measures to encourage compliance in lieu of formal proceedings such as a private, written warning; suspending fines subject to continuing compliance; medical or professional treatment as may be necessary; medical or diagnostic testing and monitoring; skills assessment; corrective training; participation in outreach programming; or contribution to the consumer fraud protection fund. The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Even compliant providers who had not conducted an in-person examination for telemedicine patients during the COVID-19 emergency would be in violation of the regulations as of January 2026 for the same practice. Practitioners should be diligent in adhering to the prescribing rules to avoid sanctions related to casual care. Likewise, attorneys advising or defending practitioners before the board must be aware of the in-person examination requirements for prescribing in New Jersey whether the care in question took place in-person or in a telemedicine setting. Reprinted with permission from the April 22, 2026 issue of the New Jersey Law Journal. ©2026 ALM Media Properties, LLC. Further duplication without permission is prohibited. All rights reserved.

News

Marshall Dennehey’s John J. Hare Brings Home Attorney of the Year Honors; Firm Named Litigation Department of the Year in Two Categories

Marshall Dennehey took home top honors in three categories at the The Legal Intelligencer’s 2026 Pennsylvania Legal Awards, held June 11 in Philadelphia. The first place awards include: Attorney of the Year: John J. Hare, Chair of the firm’s Appellate Advocacy & Post-Trial Practice Group and Executive Committee member, together with Charles “Chip” Becker of Kline & Specter Litigation Department of the Year, Appellate – Third Win in a Row! Litigation Department of the Year, Product Liability/Mass Torts “There is no one more deserving of Attorney of the Year honors than John. This award is a testament to his exceptional skill, dedication, and leadership—qualities that truly exemplify the very best of our firm,” said G. Mark Thompson, Marshall Dennehey’s President & CEO. “These honors also reflect the strength and depth of our product liability, mass torts, and appellate practices across Pennsylvania and beyond, underscoring our ongoing commitment to delivering outstanding results for our clients.” Attorney of the Year – John J. Hare, Marshall Dennehey, together with Charles “Chip” Becker, Kline & Specter Over the past year, John and Charles were opposing counsel in many of the highest-profile civil appeals in Pennsylvania. John is renowned as a preeminent appellate lawyer on the defense side, and Chip on the plaintiff's side. They have opposed each other repeatedly, exhibiting peerless professionalism and exceptional civility, while zealously litigating under the unremitting pressure of high-profile litigation and record-setting verdicts totaling more than $3.5 billion. They have also collaborated, outside of litigation, on many commissions, committees, and projects of importance to the Pennsylvania judiciary and legal community. Litigation Department of the Year – Appellate Law, Winner (previous winner, 2025 and 2024) 2025 was another standout year for the firm’s Appellate Advocacy & Post‑Trial Practice Group, led by John J. Hare, which was retained to challenge many of Pennsylvania’s “nuclear” verdicts—awards exceeding $10 million. Notably, the department persuaded the Pennsylvania Superior Court to reverse a Philadelphia judgment of $1.09 billion, the largest judgment ever overturned by a Pennsylvania appellate court. The group’s 11 full‑time Pennsylvania‑based appellate lawyers are at the center of Pennsylvania’s most high-profile matters, bringing more than 150 years of combined appellate experience. They routinely handle post‑trial and appellate matters and are frequently engaged to participate in and monitor trials in high‑exposure cases to ensure that critical legal issues are properly raised and preserved for appeal. Litigation Department of the Year – Product Liability/Mass Torts, Winner This marks the first win for the firm’s Pennsylvania Product Liability and Mass Torts practices, which operate within our Casualty Department, managed by Matthew Schorr and Jeff Rapattoni. For almost five decades, Fortune 500 product manufacturers/distributors and their insurers have turned to these groups to defend their litigation. Led by Bradley D. Remick and Vlada Tasich, our Product Liability group’s success can be attributed to its commitment to keeping abreast of ever-changing legal theories, judicial viewpoints, and evolving technology impacting the product liability landscape. Our attorneys have successfully handled thousands of product liability matters in all jurisdictions across the state. Likewise, our mass tort litigation practice – divided into Asbestos & Mass Tort, and Environmental & Toxic Tort Litigation –  has defended manufacturers, distributors, contractors, and premises owners in thousands of personal injury and other claims. Led by Kevin E. Hexstall and Patrick T. Reilly, most attorneys in these groups have more than 20 years of experience, and our seasoned trial team has tried hundreds of cases to verdict, consistently achieving strong results through both trials and settlements. In addition to these awards, Marshall Dennehey was a Litigation Department of the Year finalist for Professional Liability.

Thought Leadership

SIDEBAR: News and Happenings

We are pleased to share that attorneys from our health care team have been selected to the 2026  New Jersey and Pennsylvania Super Lawyers and Rising Stars lists. Their dedication to clients and commitment to high-quality work continues to strengthen our firm! Please join us in congratulating: NJ Super Lawyers: Robert T. Evers and Justin F. Johnson NJ Super Lawyer Rising Stars: Nataliana A. Guida  2026 Pennsylvania Super Lawyers: Alyson J. Kirleis and Gary M. Samms 2026 Pennsylvania Rising Stars: Holli K. Archer and Daniel Dolente Victoria Scanlon (Scranton) was a faculty presenter at the 2026 American Roentgen Ray Society (ARRS) Annual Meeting in Pittsburgh. She participated in the “Resident Symposium: Producing Quality Reports,” focusing her presentation on “How to Write a Great Report: Malpractice Lawyer’s Perspective.” Vicky, the only attorney presenter for this two-hour segment, was joined by several health care professionals including diagnostic radiologists, an interventional radiologist, an internal medicine physician, and a radiologist turned AI entrepreneur expert.  Matthew Keris (Scranton), President of the Pennsylvania Association for Health Care Risk Management (PAHCRM) and shareholder in our Scranton Health Care Department, presented an important and timely session titled “Keynote Address: A Conversation with RaDonda Vaught on Criminalizing Errors” at PAHCRM’s Annual Meeting in April. RaDonda is a former Tennessee nurse widely known for being criminally convicted in 2022 of negligent homicide and gross neglect after a 2017 fatal medication error at Vanderbilt University Medical Center. Her case gained national attention because she was criminally prosecuted rather than just facing licensing board action, sparking debate over blaming individual nurses for systemic healthcare failures. Matt and RaDonda’s conversation explored one of the most consequential issues in health care risk management today—how systems respond to human error, and what it means for patient safety, accountability, and the professionals who serve on the front lines. Gary Samms was a panelist for a podcast hosted by the Medical Liability Monitor, “From Outliers to Pattern: The Increasing Predictability of Megaverdicts in the Med-Mal Industry – and How to Reduce the Likelihood of Getting Hit with One.” Gary discussed the changing megaverdict landscape and why “outlier” verdicts are becoming structural, in addition to how plaintiffs turn weaknesses into megaverdicts (including building emotional narrative and jury psychology). Thank you to our clients who joined us for our Trends in Health Care & Health Law seminar on May 14. Led by our Health Care Department Director and Assistant Director, Robin Snyder and Donna Modestine, the session explored key issues that are currently shaping outcomes in health care litigation. We owe a debt of gratitude to our esteemed guest speaker, Mary Ellen Nepps, Esq., Senior Counsel, University of Pennsylvania, who presented “Medical Malpractice Litigation: Driving Another Health Care Crisis in Pennsylvania.” And special thanks to our attorneys who presented and shared their insights, including John J. Hare and Holli Archer who discussed “Highlights in PA Medical Malpractice Law;” David Drake for his presentation, “From Claims to Courtroom: Key Trends in NJ Medical Malpractice Litigation;” and Matthew Keris with an “Update on Health Care Tech Discovery.” Thank you to all of our clients for entrusting us with your health care litigation. We are proud to partner with you as we defend your interests and navigate legal landscapes together.